Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804 | ISIN: INE406A01037 | Industry: Pharmaceuticals
| Mid-range Performer
1094.4000 -14.80 (-1.33%)
NSE Sep 12, 2025 15:31 PM
Volume: 794.2K
 

1094.40
-1.33%
Axis Direct
Company Outlook & Guidance: ABRP has several growth levers in place. These are 1) Generic injectibles, Eugia ( Euro 411 Mn sales) that could grow by low double-digit growth based on value-added approval.
Promoters pledged 0.16% of shares in last quarter. Total pledge stands at 17.08% of promoter holdings
More from Aurobindo Pharma Ltd.
Recommended